Phacilitate Leaders Forum

Speakers

Loading
Marc Turner

Marc Turner

Medical Director, Scottish National Blood Transfusion Service

Marc Turner is Professor of Cellular Therapy at the University of Edinburgh and Medical Director at the Scottish National Blood Transfusion Service. He qualified in Medicine from the University of Manchester in 1982 and trained in General Medicine and Haematology.  He obtained his PhD in human haematopoietic stem cell biology from the University of Edinburgh in 1995 and an MBA in Life Sciences from the Open University in 2007.  He is a Fellow of the Royal College of Physicians of London, of the Royal College of Physicians of Edinburgh, of the Royal College of Pathologists and of the Higher Education Academy. His research interests include the risk of transmission of prion diseases by blood, tissues and cells and the translation of advanced therapy medicinal products to clinical practice. He has held 35 research grants and has 150 publications. He is currently a Non-Executive Director of Cell and Gene Therapy Catapult, Chair of the Global Alliance on iPSC Therapies and of the European Blood Alliance Tissues, Cells and Advanced Therapies Working Group. He is one of two physicians appointed by the European Commission as Members of the European Medicines Agency Committee on Advanced Therapies and is also a Member of the Commission on Human Medicines Clinical trials, Biologicals and Vaccines Expert Advisory Group. He is co-Director of the Advanced Therapy Treatment Centre covering Scotland and the North of England.

Sessions
Testimonials
  • Real thinking forward combining experts in the field from manufacturing, regulatory and value vision” – “great network with strong experience and sharing risks & opportunities
    Jean-Philippe Combal
    GenSight Biologics
  • The conference consistently proves to be a great forum for networking with industry leaders in the development of cellular and gene therapies as well as vendors for important technologies and services.
    Michael Covington
    Juno Therapeutics, Inc
  • It was a very interesting event as all participants, including speakers were ready to exchange, even on the most challenging subjects such as reimbursement, GMP guidance
    Bertrand Alexandre
    Celyad
  • Phacilitate EU delivered it's promise and more, the topics discussed were highly relevant, with very good and professional speakers and panelists. You will see me next year in Berlin.
    Dr Ohad Karnieli
    Karnieli Ltd